Department of Medicinal Chemistry, Elan Pharmaceuticals, South San Francisco, CA 94080, USA.
Bioorg Med Chem Lett. 2010 Jun 15;20(12):3502-6. doi: 10.1016/j.bmcl.2010.04.148. Epub 2010 May 6.
Significant improvement in metabolic stability on the pyrazolopiperidine scaffold over the original series were achieved and this stability improvement translated in an improved in vivo efficacy.
在吡唑并哌啶骨架上实现了代谢稳定性的显著改善,超过了原始系列,这种稳定性的提高转化为改善了体内疗效。